Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using Eggshell Calcium to Mitigate Fluorosis in Ethiopia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03355222
Recruitment Status : Active, not recruiting
First Posted : November 28, 2017
Last Update Posted : April 18, 2019
Sponsor:
Collaborator:
Hawassa University
Information provided by (Responsible Party):
Susan Whiting, University of Saskatchewan

Brief Summary:
Mothers and young children in rural Ethiopia lack sufficient nutrition, and a compounding factor is presence of high levels of fluoride (> 5-10 mg/day) affecting body functions. Interventions involving chickens to provide eggs and eggshell (a source of calcium) are one solution. The overall purpose is to examine how increasing dietary calcium by using eggshell powder (ESP) reduces fluoride (F) absorption in women. It is known calcium binds F to prevent its absorption but application of this to a community based study has not been tested. The aim is to provide chickens to produce eggs for young children and to provide ESP to women (mothers). For children, an egg a day should improve growth and nutritional status. For women, the ESP provides calcium to reduce fluorosis and therefore improve function without affecting iron and zinc status. For the women, blood samples will be tested in a subsample for F, calcium, zinc and iron; urine samples will be measured for F, calcium and creatinine (to correct spot urine). Hemoglobin will be measured as an indicator of overall nutritional status in women and children. Nutritional status of young children (6-18 mo) and of their mothers prior and after the intervention (by 6 months) will be assessed. between 6 and 12 month there will be monitoring for sustainability of chilckens in the community; for continued use of egg (in children) and ESP (in women); during this time the control group will receive chickens and also undergo monitoring. The study will take place in the Rift valley of Southern Ethiopia. Identification of the knowledge, attitude and practices (KAP) of mothers on egg consumption will be done at baseline and at the end ("endline"). Caregivers will be instructed to give each child 1 egg (cooked) per day in the intervention, and one "bottle cap" of eggshell powder (1000 mg calcium) per day for themselves. Families receiving chickens will be instructed on cage construction. Throughout the study, any problems arising in keeping chickens will be recorded in order to assess the feasibility and practicality of raising chickens as way to mitigate fluorosis and improve nutritional status.

Condition or disease Intervention/treatment Phase
Fluoride Poisoning Hemoglobin Underweight Stunting Development; Delayed, Mental Fluorosis, Dental Fluorosis; Skeletal Zinc Deficiency Behavioral: Promotion of chicken eggs Not Applicable

Detailed Description:

This is a Proof of Principle study with a treatment ("Intervention") group and a parallel control group for delivering eggshell powder to mothers in the setting of a chilken intervention. The control and intervention groups will come from the same region in southern Ethiopia where fluorosis is known to occur, with active intervention for 6 months followed by observation for a further 6 months. The Intervention is providing daily eggshell calcium to a subset of mothers, with all eligible young children receiving at least one egg a day. The treatment group consists of mothers and young children in a community where study families will receive two chickens each, and the control group are mothers and young children not having chickens for the first six months, but who will be gifted with chickens at 6 months. Along with receiving chickens, the intervention group will receive training in use of egg, as well as assistance in caring for chickens, throughout the first 6 months. In the second 6-months, the participants' use of eggs will be monitored. In the control group, provision of chickens after 6 months will be accompanied by training but for a shorter duration, and monitoring of use of egg will provide information on whether minimal support can effectively allow for adoption of new food sources into a community.

Study participants are all mothers with children aged between 6-18 months old in two participating kebeles (villages), one randomly assigned as intervention, the other as control. The age group of the child is selected because it is the time of introduction of complementary food and it will be easier to see the clear effect of egg on the children's growth. Mothers are lactating therefore at a time for maximal calcium utilization. While eggs are not commonly eaten in rural Ethiopia, it is due to expense, not to unfamiliarity. In the Intervention community prior to baseline measurements, each family of the mother-child pair will receive two chickens at a "ceremony" that marks the responsibility given to the family to provide one egg per day to the child. In a subset of mothers, they will consent to use eggshell. This is modified from what the investigators did in a pilot study (NCT02791100) and the investigators found use of egg by the child was 85% throughout the 6 month time-period. One lesson learned was to purchase older chickens that are immediately capable of laying eggs. Second, in this intervention the child will not receive ESP.

There will be formal follow-up observation at one community site with focus group discussion and key informant interviews, as a way to assess feasibility and practically of chicken donation in the future. This will be a convenience sample representing participant parents, community leaders, Agriculture Extension workers, Health extension workers, persons who were not directly involved. Those targeted for interviews will be the extension workers from whom feedback will be provided, while focus groups will be held with others who are able to attend a focus group session.

Data checks will be provided by two doctoral students working on the project. Local supervisors will provide guidance. The students have written specific operating procedures (SOP) for all procedures. Missing data will be accounted for, but as this is a community based study group means will be used for most outcome measurements. Comparing of two means/the differences of means between the intervention and control groups will be done using independent two sample t-test. Continuous outcomes will be analyzed using paired t-test. Bivariate analysis will be used to see the overall effect of independent variables and then further multivariate analysis (multiple linear regressions) will be done to see the effect of each independent variable. Both crude and adjusted risk ratio with 95% confidence interval will be reported. Other variables and relevant findings will be also analyzed using proper statistical test/analysis techniques and reported accordingly. P-value of less than 0.05 will be taken as significant

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Subjects to be drawn from two simlar villages: one is intervention village and other is control village.
Masking: None (Open Label)
Masking Description: Chickens are how we intervene and this is not possible to "blind'. Two villages will be far apart. We will not disclose nature of intervention to examiners.
Primary Purpose: Prevention
Official Title: Using Eggshell Calcium to Mitigate Fluorosis in Ethiopia
Actual Study Start Date : January 2, 2018
Actual Primary Completion Date : December 1, 2018
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium

Arm Intervention/treatment
No Intervention: No Intervention
No intervention: The community receives no chickens and no special education is provided.
Experimental: Experimental: providing chickens and egg shell

Experimental: Two chickens are given to each family so that eggs are available for children and of eggshell powder for mothers.

The community receives these chickens so each designated family has an egg to give to young child. In a subgroup the mother will receive ESP (1000 mg calcium). The community receives information on using egg and has help on caring for chickens.

Behavioral: Promotion of chicken eggs
Community is provided with chickens and young children are to receive one egg a day; selected mothers will consume eggshell.




Primary Outcome Measures :
  1. Apparent fluoride absorption [ Time Frame: 6 months ]
    Change in urinary fluoride corrected for creatinine as a measure of F absorption


Secondary Outcome Measures :
  1. Growth in young children [ Time Frame: 6 months and 12 months ]
    weight for age

  2. Functional indicators of fluorosis [ Time Frame: 6 months ]
    Physical signs of fluorosis are assessment using a standard questionnaire developed by the investigators and subsequently published (Kebede et al., 2016). Briefly this consists of a questionnaire of signs and symptoms which can be added to obtain a score

  3. Hemoglobin (Hb) [ Time Frame: 6 months and 12 months ]
    Blood levels of Hb

  4. Knowledge, attitude and practices (KAP) for egg [ Time Frame: 6 and 12 months ]
    Questionnaire assessment of KAP

  5. Linear growth in young children [ Time Frame: 6 months and 12 months ]
    length for age


Other Outcome Measures:
  1. Inhibition of zinc absorption [ Time Frame: 6 months ]
    serum zinc



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Months to 18 Months   (Child)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Children will be male and female but "mothers" will only be female.
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All women with a child age 6 to 18 months and their child living permanently in the village
  • the woman does not have to be biological mother Exclusion Criteria:
  • Exclude families with a child who is known to be allergic to egg
  • Exclude families with a child who is diagnosed as malnourished (moderate malnutrition (MAM) or severe malnutrition (SAM)
  • Exclude women who do not live with the child

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03355222


Locations
Layout table for location information
Ethiopia
Hawassa University
Hawassa, Ethiopia
Sponsors and Collaborators
University of Saskatchewan
Hawassa University
Investigators
Layout table for investigator information
Principal Investigator: Susan Whiting, PhD University of Saskatchewan
Publications:
Kebede A, N Retta, C Abuye, SJ Whiting, M Kassaw, T Zeru, MW Yohannes, D Zerfu, M Tessema, MK. Malde. Minimizing bioavailability of fluoride through addition of calcium-magnesium citrate or a calcium and magnesium-containing vegetable to the diets of growing rats. International Journal of Biochemistry Research & Review. 10(2): 1-8. 2016a

Layout table for additonal information
Responsible Party: Susan Whiting, Professor of Nutrition, University of Saskatchewan
ClinicalTrials.gov Identifier: NCT03355222    
Other Study ID Numbers: HU-UoS-EGGSHELL-FLUORIDE
First Posted: November 28, 2017    Key Record Dates
Last Update Posted: April 18, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: We would find it difficult to keep records for extraction of participant data as the local language will be used to store records.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Susan Whiting, University of Saskatchewan:
complementary feeding
calcium
Additional relevant MeSH terms:
Layout table for MeSH terms
Fluorosis, Dental
Thinness
Poisoning
Fluoride Poisoning
Chemically-Induced Disorders
Body Weight
Signs and Symptoms
Tooth Diseases
Stomatognathic Diseases